De Kam, Pieter-Jan <br/><br/>
Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects.  [electronic resource] 

 -  International journal of clinical pharmacology and therapeutics  Aug 2014 
 - 631-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0946-1965 
<br/><br/><label>Standard No.: </label>10.5414/CP202091  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Anticoagulants--pharmacology<br/>Cross-Over Studies<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Interactions<br/>Enoxaparin--pharmacology<br/>Factor Xa Inhibitors<br/>Heparin--pharmacology<br/>Humans<br/>Male<br/>Middle Aged<br/>Partial Thromboplastin Time<br/>Sugammadex<br/>Young Adult<br/>gamma-Cyclodextrins--administration & dosage